VEGFA and osteonecrosis: Based on the previous research, we put forward our hypothesis that Src inhibitor blocking aberrant VEGF-Src signaling could inhibit both vascular event (continuous marrow edema) and skeletal event (persistent bone resorption) of destructive repair but preserve VEGF-induced neovascularization in steroid-associated osteonecrosis.